Leukemic stem cells and measurable residual disease in AML: An emerging new outcome parameter

W. Zeijlemaker

    Research output: PhD ThesisPhD Thesis - Research VU Amsterdam, graduation VU Amsterdam

    512 Downloads (Pure)
    Original languageEnglish
    QualificationPhD
    Awarding Institution
    • Vrije Universiteit Amsterdam
    Supervisors/Advisors
    • Ossenkoppele, G.J., Supervisor, External person
    • Schuurhuis, G.J., Co-supervisor, External person
    Award date22 Nov 2017
    Print ISBNs9789463322393
    Publication statusPublished - 2017

    Keywords

    • acute myeloid leukemia
    • minimal/measurable residual disease
    • leukemic stem cells

    Cite this